Cooper Total Current Assets 2010-2024 | COO

Cooper total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Cooper total current assets for the quarter ending July 31, 2024 were $1.927B, a 12.61% increase year-over-year.
  • Cooper total current assets for 2023 were $1.705B, a 11.17% increase from 2022.
  • Cooper total current assets for 2022 were $1.534B, a 4.66% increase from 2021.
  • Cooper total current assets for 2021 were $1.465B, a 15% increase from 2020.
Cooper Annual Total Current Assets
(Millions of US $)
2023 $1,705
2022 $1,534
2021 $1,465
2020 $1,274
2019 $1,163
2018 $1,091
2017 $953
2016 $937
2015 $841
2014 $792
2013 $747
2012 $658
2011 $540
2010 $491
2009 $504
Cooper Quarterly Total Current Assets
(Millions of US $)
2024-07-31 $1,927
2024-04-30 $1,859
2024-01-31 $1,794
2023-10-31 $1,705
2023-07-31 $1,711
2023-04-30 $1,599
2023-01-31 $1,578
2022-10-31 $1,534
2022-07-31 $1,598
2022-04-30 $1,738
2022-01-31 $1,698
2021-10-31 $1,465
2021-07-31 $1,475
2021-04-30 $1,323
2021-01-31 $1,297
2020-10-31 $1,274
2020-07-31 $1,321
2020-04-30 $1,166
2020-01-31 $1,150
2019-10-31 $1,163
2019-07-31 $1,151
2019-04-30 $1,137
2019-01-31 $1,193
2018-10-31 $1,091
2018-07-31 $1,189
2018-04-30 $1,272
2018-01-31 $1,176
2017-10-31 $953
2017-07-31 $932
2017-04-30 $958
2017-01-31 $884
2016-10-31 $937
2016-07-31 $930
2016-04-30 $915
2016-01-31 $845
2015-10-31 $841
2015-07-31 $815
2015-04-30 $800
2015-01-31 $787
2014-10-31 $792
2014-07-31 $896
2014-04-30 $765
2014-01-31 $701
2013-10-31 $747
2013-07-31 $706
2013-04-30 $676
2013-01-31 $681
2012-10-31 $658
2012-07-31 $628
2012-04-30 $576
2012-01-31 $555
2011-10-31 $540
2011-07-31 $544
2011-04-30 $538
2011-01-31 $503
2010-10-31 $491
2010-07-31 $491
2010-04-30 $493
2010-01-31 $496
2009-10-31 $504
2009-07-31 $518
2009-04-30 $525
2009-01-31 $537
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $19.898B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
West Pharmaceutical Services (WST) United States $23.239B 47.47
Labcorp (LH) United States $20.088B 16.66
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49